Why technology standards are critical for Quantum-Safe Security

Safeguard Insights

September 14, 2010

Safeguard Scientifics Investor Day 2010

On Tuesday, Oct. 5, Safeguard Scientifics will be hosting Investor Day 2010 from 8 a.m. to 11:30 a.m. EDT at The Yale Club of New…

Posted by John E. Shave III

September 10, 2010

Advancements in Diagnostics

Advances in the life sciences will continue to have a far-reaching impact on virtually every aspect of our society. There is an abundance of companies…

Posted by James A. Datin

July 14, 2010

Video: James A. Datin Talks About Safeguard Scientifics’ Life Sciences Strategy

James A. Datin, Executive Vice President and Managing Director of Life Sciences Group at Safeguard Scientifics, discusses his thoughts on the opportunities in life sciences…

Posted by John E. Shave III

July 12, 2010

Bloomberg Businessweek says Avid likely to Beat GE, Bayer to Market

On the eve of the International Conference on Alzheimer’s Disease (ICAD), Bloomberg Businessweek’s Elizabeth Lopatto and Kanoko Matsuyama reported that Avid Radiopharmaceuticals, Inc., a Safeguard…

Posted by James A. Datin

July 1, 2010

The Next Frontier: Opportunities in Regenerative Medicine

While there are a wealth of opportunities to deploy capital in a variety of life sciences companies, the evolution and potential long-term impact of regenerative…

Posted by James A. Datin

June 24, 2010

New York Times puts Avid’s Technology Front and Center

Avid Radiopharmaceuticals was featured on the front page of The New York Times today. The article, “Promise Seen for Detection of Alzheimer’s,” by Gina Kolata (@ginakolata), highlights…

Posted by James A. Datin

May 21, 2010

Diagnostic Imaging Continues to Garner Investor Interest

On the heels of the BIO International Convention, I came across this piece by FierceBiotech’s Maureen Martino highlighting a panel of biotech VCs who made…

Posted by James A. Datin

February 22, 2010

Molecular Biometrics Attracts Another $12.5 Million

Molecular Biometrics, Inc., one of Safeguard Scientifics’ Life Sciences partner companies, raised another $12.5 million of capital. The new capital will support three big goals.…

Posted by John E. Shave III

February 2, 2010

Safeguard Scientifics’ Jim Datin Discusses Biotech Investing Trends in 2010

James A. Datin, EVP and Managing Director of Safeguard Scientifics‘ Life Sciences Group, was recently interviewed by FierceBiotech, a leading industry online publication, about biotech…

Posted by John E. Shave III

Content